A review of rhythm disorders in cardiac hypertrophy

J M McLenachan1, H J Dargie

  • 1Department of Cardiology, Western Infirmary, Glasgow, United Kingdom.

Insights

Ventricular arrhythmias are common in left ventricular hypertrophy, likely due to fibrosis. Antiarrhythmic therapy might reduce mortality in severe cases, though further study is needed.

Area of Science:

  • Cardiology
  • Pathophysiology

Background:

  • Left ventricular hypertrophy (LVH) is associated with frequent ventricular arrhythmias.
  • The underlying mechanisms of these arrhythmias are not fully understood.

Purpose of the Study:

  • To investigate the relationship between left ventricular hypertrophy and ventricular arrhythmias.
  • To explore potential therapeutic strategies for managing arrhythmias in LVH.

Main Methods:

  • The study reviewed existing experimental and human data on ventricular arrhythmias in LVH.
  • Analysis focused on the role of hypertrophy-related fibrosis versus other potential causes.

Main Results:

  • Ventricular arrhythmias in LVH appear primarily linked to the hypertrophic process and associated fibrosis.
  • Coronary artery disease and hypokalemia were less likely causative factors.

Conclusions:

  • Fibrosis associated with left ventricular hypertrophy is a key factor in ventricular arrhythmias.
  • Antiarrhythmic therapy may offer mortality benefits in selected hypertensive patients with severe LVH, warranting further investigation.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...